vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and IDEX Corporation (IEX). Click either name above to swap in a different company.
IDEX Corporation is the larger business by last-quarter revenue ($398.4M vs $359.9M, roughly 1.1× AdvanSix Inc.). IDEX Corporation runs the higher net margin — 30.1% vs -0.8%, a 30.9% gap on every dollar of revenue. On growth, IDEX Corporation posted the faster year-over-year revenue change (16.7% vs 9.4%). IDEX Corporation produced more free cash flow last quarter ($86.0M vs $36.1M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -29.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.
ASIX vs IEX — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $398.4M |
| Net Profit | $-2.8M | $120.0M |
| Gross Margin | 7.6% | 99.9% |
| Operating Margin | -0.7% | 43.3% |
| Net Margin | -0.8% | 30.1% |
| Revenue YoY | 9.4% | 16.7% |
| Net Profit YoY | -892.9% | 25.7% |
| EPS (diluted) | $-0.11 | $1.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | — | $398.4M | ||
| Q1 26 | — | $407.7M | ||
| Q4 25 | $359.9M | $899.1M | ||
| Q3 25 | $374.5M | $878.7M | ||
| Q2 25 | $410.0M | $865.4M | ||
| Q1 25 | $377.8M | $814.3M | ||
| Q4 24 | $329.1M | $862.9M | ||
| Q3 24 | $398.2M | $798.2M |
| Q2 26 | — | $120.0M | ||
| Q1 26 | — | $128.3M | ||
| Q4 25 | $-2.8M | $128.3M | ||
| Q3 25 | $-2.6M | $127.8M | ||
| Q2 25 | $31.4M | $131.6M | ||
| Q1 25 | $23.3M | $95.5M | ||
| Q4 24 | $352.0K | $123.2M | ||
| Q3 24 | $22.3M | $119.1M |
| Q2 26 | — | 99.9% | ||
| Q1 26 | — | 94.9% | ||
| Q4 25 | 7.6% | 43.1% | ||
| Q3 25 | 6.8% | 44.5% | ||
| Q2 25 | 14.3% | 45.3% | ||
| Q1 25 | 14.2% | 45.3% | ||
| Q4 24 | 3.4% | 42.5% | ||
| Q3 24 | 14.4% | 44.3% |
| Q2 26 | — | 43.3% | ||
| Q1 26 | — | 45.0% | ||
| Q4 25 | -0.7% | 20.4% | ||
| Q3 25 | -0.9% | 21.1% | ||
| Q2 25 | 7.7% | 21.7% | ||
| Q1 25 | 7.7% | 17.4% | ||
| Q4 24 | -3.9% | 19.2% | ||
| Q3 24 | 7.5% | 21.0% |
| Q2 26 | — | 30.1% | ||
| Q1 26 | — | 31.5% | ||
| Q4 25 | -0.8% | 14.3% | ||
| Q3 25 | -0.7% | 14.5% | ||
| Q2 25 | 7.7% | 15.2% | ||
| Q1 25 | 6.2% | 11.7% | ||
| Q4 24 | 0.1% | 14.3% | ||
| Q3 24 | 5.6% | 14.9% |
| Q2 26 | — | $1.61 | ||
| Q1 26 | — | $1.71 | ||
| Q4 25 | $-0.11 | $1.71 | ||
| Q3 25 | $-0.10 | $1.70 | ||
| Q2 25 | $1.15 | $1.74 | ||
| Q1 25 | $0.86 | $1.26 | ||
| Q4 24 | $0.02 | $1.61 | ||
| Q3 24 | $0.82 | $1.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $586.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $4.0B |
| Total Assets | $1.7B | $6.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $586.2M | ||
| Q1 26 | — | $580.0M | ||
| Q4 25 | $19.8M | $580.0M | ||
| Q3 25 | $23.7M | $593.8M | ||
| Q2 25 | $18.4M | $568.2M | ||
| Q1 25 | $8.3M | $594.1M | ||
| Q4 24 | $19.6M | $620.8M | ||
| Q3 24 | $17.3M | $633.2M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.1B |
| Q2 26 | — | $4.0B | ||
| Q1 26 | — | $4.0B | ||
| Q4 25 | $815.2M | $4.0B | ||
| Q3 25 | $818.2M | $4.0B | ||
| Q2 25 | $823.7M | $4.0B | ||
| Q1 25 | $794.4M | $3.9B | ||
| Q4 24 | $774.6M | $3.8B | ||
| Q3 24 | $766.4M | $3.8B |
| Q2 26 | — | $6.9B | ||
| Q1 26 | — | $6.9B | ||
| Q4 25 | $1.7B | $6.9B | ||
| Q3 25 | $1.7B | $7.0B | ||
| Q2 25 | $1.6B | $6.9B | ||
| Q1 25 | $1.6B | $6.8B | ||
| Q4 24 | $1.6B | $6.7B | ||
| Q3 24 | $1.5B | $7.0B |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | — |
| Free Cash FlowOCF − Capex | $36.1M | $86.0M |
| FCF MarginFCF / Revenue | 10.0% | 21.6% |
| Capex IntensityCapex / Revenue | 7.7% | 4.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $654.3M |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $209.5M | ||
| Q3 25 | $26.6M | $203.5M | ||
| Q2 25 | $21.1M | $161.7M | ||
| Q1 25 | $11.4M | $105.7M | ||
| Q4 24 | $64.2M | $172.6M | ||
| Q3 24 | $57.3M | $205.3M |
| Q2 26 | — | $86.0M | ||
| Q1 26 | — | $189.8M | ||
| Q4 25 | $36.1M | $189.8M | ||
| Q3 25 | $66.0K | $188.7M | ||
| Q2 25 | $-7.2M | $146.9M | ||
| Q1 25 | $-22.6M | $91.4M | ||
| Q4 24 | $29.8M | $157.1M | ||
| Q3 24 | $26.8M | $191.6M |
| Q2 26 | — | 21.6% | ||
| Q1 26 | — | 46.6% | ||
| Q4 25 | 10.0% | 21.1% | ||
| Q3 25 | 0.0% | 21.5% | ||
| Q2 25 | -1.7% | 17.0% | ||
| Q1 25 | -6.0% | 11.2% | ||
| Q4 24 | 9.1% | 18.2% | ||
| Q3 24 | 6.7% | 24.0% |
| Q2 26 | — | 4.4% | ||
| Q1 26 | — | 15.6% | ||
| Q4 25 | 7.7% | 2.2% | ||
| Q3 25 | 7.1% | 1.7% | ||
| Q2 25 | 6.9% | 1.7% | ||
| Q1 25 | 9.0% | 1.8% | ||
| Q4 24 | 10.4% | 1.8% | ||
| Q3 24 | 7.7% | 1.7% |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 1.63× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | 0.67× | 1.23× | ||
| Q1 25 | 0.49× | 1.11× | ||
| Q4 24 | 182.29× | 1.40× | ||
| Q3 24 | 2.57× | 1.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
IEX
Segment breakdown not available.
